The novel approach of this peptide represents a major development in the handling of the condition. Unlike existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – leading to https://tirzepatide-peptide043695.verybigblog.com/40783432/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment